• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number Clinical Pharmacology Advisory Committee meetings and OCP Co-sponsor meetings (i.e. Drug Information Association (DIA), Pharmaceutical Research and Manufacturers of America (PhRMA)) that OCP co-organizes and presents per quarter

Measure was implemented starting February 2010

Dictionary: These meetings with external parties are intended to resolve equivocal scientific issues that lead to clear policy for industry.

This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.

Fiscal Year - 2010

Skip graphic and jump to text data

Measure was implemented starting February 2010

Feb 2010N/A1
Mar 2010N/A1
Apr 2010N/A0
May 2010N/A0
Jun 2010N/A1
Jul 2010N/A0
Aug 2010N/A0
Sep 2010N/A1


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.